Minox 5, 50 mg ml, cutaneous solution_ Public assessment summary report_Package label
Minox 5, 50 mg ml, cutaneous solution_ Public assessment summary report_Package label
Delstrigo 100 mg 300 mg 245 mg film-coated tablets_ Public assessment summary report_Package label-1
Delstrigo 100 mg 300 mg 245 mg film-coated tablets_ Public assessment summary report_Package label-1
CELMANTIN 10 mg and 20 mg film-coated tablets_public assessment summary report_Package label
CELMANTIN 10 mg and 20 mg film-coated tablets_public assessment summary report_Package label-
Delstrigo100 mg 300 mg 245 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
Delstrigo100 mg 300 mg 245 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
CELMANTIN 10 mg and 20 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
CELMANTIN 10 mg and 20 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets Summary of product Characteristics
Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets Summary of product Characteristics
Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets_Public assessment summary report and packaging material
Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets_Public assessment summary report and packaging material
Definition of Organization, Powers and Duties of the Ethiopian Food and Drug Authority Council of Ministers Regulation No. 531/2023
Definition of Organization Powers and Duties of the Ethiopian Food and Drug Authority Council of Ministers Regulation No 531 2023
Summary of product Characteristics of Sildenafil Citrate 50
Summary of product Characteristics of Sildenafil Citrate 50
Public assessment summary report of sildenafil
Public assessment summary report of sildenafil